Healthpeak Properties (NYSE:DOC – Get Free Report) was upgraded by equities researchers at The Goldman Sachs Group to a “hold” rating in a research report issued to clients and investors on Friday, MarketBeat reports.
DOC has been the topic of a number of other research reports. Robert W. Baird reduced their target price on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a report on Wednesday, November 12th. Wells Fargo & Company lifted their price objective on Healthpeak Properties from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 25th. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday. Jefferies Financial Group downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their target price for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Monday, December 29th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $19.67.
View Our Latest Stock Analysis on DOC
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. During the same quarter last year, the business earned $0.45 EPS. Healthpeak Properties’s revenue for the quarter was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current year.
Institutional Trading of Healthpeak Properties
A number of hedge funds have recently made changes to their positions in the company. State Street Corp boosted its stake in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares during the period. JPMorgan Chase & Co. lifted its holdings in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC boosted its position in Healthpeak Properties by 1.0% in the 2nd quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock valued at $332,625,000 after buying an additional 197,540 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Healthpeak Properties by 2.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock valued at $184,208,000 after acquiring an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC grew its stake in shares of Healthpeak Properties by 6.7% during the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after acquiring an additional 641,771 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Why Trump and Musk suddenly care about Fort Knox
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
